Physician
Bellaire Pediatrics, P.A.
Bellaire Pediatrics, P.A. was paid $5.74M by Medicaid between Jul 2019 and Dec 2024, across 84 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 21% of everything it billed.
33Billing provider infoBELLAIRE PEDIATRICS, P.A.
HOUSTON, TX 77036
HOUSTON, TX 77036
33aNPI1528563780assigned 03/28/2018
33bProvider typePediatrics Physician
28Total paid$5.74M
24GClaims209,128
24DCodes billed84
24AFirst – last monthJul 2019 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#72 of 1,136
Median peer was paid$329K
This provider vs. median17×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 160 | $4K | |
| 2020 | 13,444 | $281K | |
| 2021 | 36,735 | $806K | |
| 2022 | 55,470 | $1.41M | |
| 2023 | 55,308 | $1.63M | |
| 2024incomplete | 48,011 | $1.62M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21% | 30,394 | 24,234 | $1.18M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.8% | 10,177 | 9,070 | $562K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 8.2% | 5,845 | 5,499 | $473K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 6.1% | 2,621 | 2,401 | $351K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 5.9% | 8,041 | 7,398 | $338K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.8% | 3,990 | 3,956 | $336K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.9% | 23,694 | 9,685 | $280K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.7% | 2,987 | 2,950 | $270K |
| S9470 | Nutritional counseling, dietitian visit | 4.6% | 8,747 | 8,208 | $262K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.3% | 3,073 | 2,984 | $248K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.2% | 1,862 | 1,838 | $182K |
| 87634 | 2.9% | 2,884 | 2,687 | $168K |
72 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.7% | 2,934 | $155K |
| 99203 | Doctor's office visit, new patient (routine) | 2.4% | 2,237 | $138K |
| 99429 | 2.2% | 3,683 | $129K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.5% | 6,064 | $87K |
| 94060 | 1.4% | 2,151 | $79K | |
| 99000 | 1.2% | 6,758 | $70K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 4,248 | $61K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 556 | $52K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 8,366 | $51K |
| 99381 | <1% | 517 | $43K | |
| 92552 | <1% | 4,161 | $25K | |
| 99383 | <1% | 233 | $22K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 3,037 | $21K |
| 90461 | <1% | 4,843 | $18K | |
| 99051 | <1% | 2,920 | $16K | |
| 83655 | <1% | 1,479 | $16K | |
| 99382 | <1% | 151 | $14K | |
| 0071A | <1% | 255 | $10K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 964 | $10K |
| 0072A | <1% | 233 | $9K | |
| 99050 | <1% | 604 | $9K | |
| 99442 | <1% | 196 | $8K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 83 | $7K |
| 85018 | <1% | 6,050 | $7K | |
| 0001A | <1% | 179 | $7K | |
| 0002A | <1% | 159 | $7K | |
| 97169 | <1% | 200 | $3K | |
| 99384 | <1% | 30 | $3K | |
| 87807 | <1% | 279 | $3K | |
| 0081A | <1% | 53 | $2K | |
| 96160 | <1% | 3,036 | $2K | |
| 17250 | <1% | 30 | $2K | |
| 81002 | <1% | 450 | $1K | |
| 0074A | <1% | 33 | $1K | |
| 69210 | <1% | 29 | $1K | |
| 0082A | <1% | 18 | $732.00 | |
| 0004A | <1% | 20 | $648.00 | |
| 0003A | <1% | 12 | $520.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 27 | $264.72 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 28 | $123.78 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 2,156 | $90.38 |
| 99072 | <1% | 258 | $51.00 | |
| 90686 | <1% | 4,106 | $41.25 | |
| 90671 | <1% | 1,543 | $4.91 | |
| 91307 | <1% | 543 | $0.93 | |
| 91300 | <1% | 428 | $0.47 | |
| 90651 | <1% | 1,083 | $0.44 | |
| 90621 | <1% | 302 | $0.22 | |
| 91308 | <1% | 81 | $0.17 | |
| 90734 | <1% | 789 | $0.14 | |
| 90380 | <1% | 65 | $0.07 | |
| 90715 | <1% | 285 | $0.07 | |
| 90716 | <1% | 1,400 | $0.03 | |
| 90707 | <1% | 1,356 | $0.03 | |
| 90723 | 0% | 1,366 | $0.00 | |
| 90698 | 0% | 584 | $0.00 | |
| 1031F | 0% | 4,695 | $0.00 | |
| S9451 | Exercise classes, non-physician provider, per session | 0% | 913 | $0.00 |
| 90680 | 0% | 1,976 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 909 | $0.00 |
| 90656 | 0% | 556 | $0.00 | |
| 36416 | 0% | 794 | $0.00 | |
| 90381 | 0% | 17 | $0.00 | |
| 0240U | 0% | 43 | $0.00 | |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | 0% | 102 | $0.00 |
| 90660 | 0% | 270 | $0.00 | |
| 90648 | 0% | 2,224 | $0.00 | |
| 90633 | 0% | 1,636 | $0.00 | |
| 99173 | 0% | 3,799 | $0.00 | |
| 90700 | 0% | 1,312 | $0.00 | |
| 90713 | 0% | 484 | $0.00 | |
| 90670 | 0% | 1,432 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLIU, NA (MEDICAL DIRECTOR)